These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 9816023

  • 1. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

  • 2. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K, Kobayashi M, Kojima H, Hirabayashi N, Kataoka M, Araki K, Matsui T, Takiyama W, Miyashita Y, Nakazato H, Nakao A, Sakamoto J.
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [Abstract] [Full Text] [Related]

  • 3. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S, Atkins M, Karp D, Neuberg D, Haynes H, Dutcher JP.
    Cancer J Sci Am; 1998 Jun; 4(4):261-8. PubMed ID: 9689985
    [Abstract] [Full Text] [Related]

  • 4. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
    Wadler S, Haynes H, Rozenblit A, Hu X, Kaleya R, Wiernik PH.
    Cancer J Sci Am; 1998 Jun; 4(5):331-7. PubMed ID: 9815298
    [Abstract] [Full Text] [Related]

  • 5. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [Abstract] [Full Text] [Related]

  • 6. 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.
    Berglund A, Carlsson G, Gustavsson B, Frödin JE, Ragnhammar P, Glimelius B.
    Anticancer Res; 2003 Dec 01; 23(2C):1789-94. PubMed ID: 12820460
    [Abstract] [Full Text] [Related]

  • 7. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F, Avallone A, McLeod H, Cartenì G, De Vita F, Casaretti R, Morsman J, Blackie R, Budillon A, De Lucia L, Gravina A, Catalano G, Comella P, Comella G.
    Clin Cancer Res; 1999 Dec 01; 5(12):3948-55. PubMed ID: 10632324
    [Abstract] [Full Text] [Related]

  • 8. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C.
    Cancer Invest; 1999 Dec 01; 17(1):1-9. PubMed ID: 10999043
    [Abstract] [Full Text] [Related]

  • 9. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ, Burris H, Schellens JH, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Fields S, Von Hoff DD, Verweij J.
    Clin Cancer Res; 1998 May 01; 4(5):1153-8. PubMed ID: 9607572
    [Abstract] [Full Text] [Related]

  • 10. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.
    François E, Ychou M, Ducreux M, Bertheault-Cvitkovic F, Giovannini M, Conroy T, Lemanski C, Thomas O, Magnin V, Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer.
    Eur J Cancer; 2005 Dec 01; 41(18):2861-7. PubMed ID: 16297614
    [Abstract] [Full Text] [Related]

  • 11. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 12. [Progress in development of chemotherapy of colorectal carcinoma].
    Köhne CH.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():33-7. PubMed ID: 8692117
    [Abstract] [Full Text] [Related]

  • 13. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
    Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Blum RH, Zeleniuch-Jacquotte A.
    Clin Cancer Res; 1997 Aug 12; 3(8):1245-52. PubMed ID: 9815806
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 Aug 12; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    Cancer and Leukemia Group B 89901Massachusetts General Hospital Cancer Center, Boston MA 02114, USA. dpryan@partners.org, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ.
    J Clin Oncol; 2006 Jun 01; 24(16):2557-62. PubMed ID: 16636336
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of high-dose etoposide phosphate in man.
    Fields SZ, Budman DR, Young RR, Kreis W, Ingram R, Schulman P, Cherny RC, Wright J, Behr J, Snow C, Schacter LP.
    Bone Marrow Transplant; 1996 Nov 01; 18(5):851-6. PubMed ID: 8932836
    [Abstract] [Full Text] [Related]

  • 17. Intermittent continuous infusion of 5-fluorouracil in combination with epirubicin and cisplatin in advanced gastric cancer: the importance of dose intensity.
    Poorter RL, Bakker PJ, Fockens P, Taat CW, Bartelsman JF, Veenhof CH.
    J Infus Chemother; 1996 Nov 01; 6(2):87-91. PubMed ID: 8809656
    [Abstract] [Full Text] [Related]

  • 18. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 19. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Sep 15; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 20. A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
    Souglakos J, Kakolyris S, Vardakis N, Androulakis N, Mavroudis D, Vamvakas L, Kouroussis C, Agelaki S, Saridaki Z, Georgoulias V.
    Cancer Invest; 2005 Sep 15; 23(6):505-10. PubMed ID: 16203658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.